NASHUA, N.H., March 11, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global leader in clinically proven AI-powered cancer…
Enhanced assay granted approval by New York State’s Clinical Lab Evaluation Program (CLEP) for patients with DLBCL clonoSEQ is the…
Delivered record full-year total revenue and AVISE CTD average selling priceImproved full-year adjusted EBITDA loss and cash use by over…
Achieved record quarterly sales of $11.4 million in Q4 2024, an increase of 27% compared with Q4 2023 Full year…
New Risk Adjustment Platform boosts accuracy and efficiency, enhancing patient outcomes, planperformance, and revenue SEATTLE, March 10, 2025 /PRNewswire/ -- Milliman…
Five times more adults on Dupixent achieved sustained disease remission at 36 weeks compared to placebo; significant reductions were also…
Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD Five times more adults on Dupixent achieved sustained disease…
TAMPA, Fla., March 7, 2025 /PRNewswire/ -- As Obesity Care Week (OCW) 2025 comes to a close, organizers and supporters…
The partnership enables Medicaid, Medicare and other health insurance members to redeem benefits for healthy food and everyday health care…
Policy, Pricing, and Reimbursement Expert Jeff Baab to Keynote on Industry's Significant Pressures Executive Fireside Chat on Industry Risk Features…